Journal
TRANSPLANTATION
Volume 82, Issue 12, Pages 1738-1743Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.tp.0000244932.29542.9e
Keywords
CD4(+)CD25(+) regulatory T cells; indirect allospecificity; adoptive cell therapy; transplantation tolerance
Categories
Ask authors/readers for more resources
Background. Harnessing naturally arising CD4(+)CD25(+) regulatory T cells (T-regs) for potential adoptive cell therapy ishampered by their innate autoreactivity and their limited number. Methods. CD4(+)CD25(+) T-regs were purified from peripheral blood of human leukocyte antigen (HLA) DRI*0101(+)A2(-) individuals, and stimulated with autologous monocyte-derived dendritic cells (DCs). Results. Here we show that CD4(+)CD25(+) T-regs specific for an HLA A2 (103-120) peptide can be selected from the peripheral blood CD4(+)CD25(+) T cell population of a healthy individual and detected using a tetramer comprised of HLA DRB1*0101 and the A2 peptide. The selected cells can be expanded substantially (i.e., a 1600-fold increase over a two-week period) by T-cell receptor (TCR) stimulation and high-doses of interleukin-2 (IL-2). The CD4(+)CD25(+) T-regs with indirect allospecificity for the A2 peptide showed more potent antigen-specific suppression than polyclonal CD4(+)CD25(+) T-regs. Conclusions. These data may pave the way for clinical studies using CD,4(+)CD25(+) Tregs with indirect allospecificity as therapeutic reagents for the induction of donor-specific transplantation tolerance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available